Table 1 Characteristics of participants
From: Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study
Characteristic | Overall, n = 2326 (100%)1 |
|---|---|
Gender (n, %) | |
Female | 1182 (53.35%) |
Male | 1144 (46.65%) |
Age (years) | 68.00 (63.00, 74.00) |
Age group (n, %) | |
60–69 years | 1184 (53.36%) |
70–79 years | 640 (27.04%) |
≥ 80 years | 502 (19.60%) |
Race (n, %) | |
Non-Hispanic White | 1190 (80.23%) |
Non-Hispanic Black | 521 (7.89%) |
Other Hispanic | 225 (3.52%) |
Mexican American | 200 (3.42%) |
Other/multiracial | 190 (4.94%) |
PIR (%) | 3.18 (1.70, 5.00) |
Alcohol intake (n, %) | |
No | 702(26.67%) |
Yes | 1624 (73.33%) |
Smoking status (n, %) | |
Never smoker | 1134 (49.65%) |
Former smoker | 899 (39.31%) |
Current smoker | 293 (11.04%) |
BMI (kg/m2) | 28.10 (24.80, 32.10) |
BMI group | |
Underweight (< 18.5) | 29.00 (1.23%) |
Normal (18.5–25) | 580.00 (24.97%) |
Overweight (25–30) | 822.00 (36.39%) |
Obese (≥ 30) | 895.00 (37.41%) |
Total calories (kcal) | 1810 (1424.66, 2273.71) |
Total VB2 intake (mg) | 2.54 (1.70, 3.89) |
CERAD Trial 1 Recall | 5.00 (4.00, 6.00) |
CERAD Trial 2 Recall | 7.00 (6.00, 8.00) |
CERAD Trial 3 Recall | 8.00 (7.00, 9.00) |
CERAD total | 20.00 (17.00, 23.00) |
CERAD Delayed Recall | 7.00 (5.00, 8.00) |
AFT | 18.00 (14.00, 22.00) |
DSST | 54.00 (42.00, 64.00) |
ALT (U/L) | 20.00 (16.00, 25.00) |
AST (U/L) | 23.00 (20.00, 27.00) |
Cholesterol (mmol/L) | 4.89 (4.14, 5.66) |